$NCSM

WILLIAMS DEWAYNE sold (to issuer) 3,061 shares of NCSM

WILLIAMS DEWAYNE (Vice President and Controller) sold (to issuer) 3,061 shares of NCS Multistage Holdings, Inc. (NCSM) on 2026-09-01.

Original reporting
SEC EDGAR · WILLIAMS DEWAYNE
Published Sep 1, 2026, 1:33 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 1, 2026, 1:35 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$NCSM
Neutral
high confidence
Mentioned
$NCSM
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$NCSMNeutralLow
01

Why it matters

The disclosed sale is routine and small; market impact is expected to be negligible.

02

Market read

Limited relevance; only of interest to existing shareholders and short‑term traders monitoring insider activity.

03

What to watch

Potential upcoming dilution or financing events not disclosed in the filing.

Relevance 4/10Novelty 4/10Timing: 2026-09-01 filing

Background

SEC Form 4 filings report insider transactions; they are primary sources for insider activity.

Company-level read

Ticker impact

$NCSMNeutralHigh confidence
Context

Form 4 disclosed Vice President Williams Dewayne sold 3,061 shares of NCS Multistage Holdings, reducing his holding to zero.

Expected impact

No significant impact; price may stay flat.

Evidence & confidence

The sale size is modest and the insider held no shares after; market typically views such routine disposals as low relevance.

Market effects

None; the filing pertains to a single micro‑cap company.

None; limited to the company's shareholders.

None

Counterpoint

If the insider had insider knowledge, the sale could hint at upcoming negative news.

Key entities

  • Williams Dewayne

    Vice President and Controller of NCS Multistage Holdings.

  • NCS Multistage Holdings, Inc.

    Issuer of the shares sold.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$SIONMed

RA CAPITAL MANAGEMENT, L.P. (Kolchinsky Peter, Shah Rajeev M.) sold $21.8M of SION (indirect holdings)

RA CAPITAL MANAGEMENT, L.P. sold 3,448,811 indirectly-held shares of Sionna Therapeutics, Inc. (SION) at an average of $6.33 ($6.32–$7.46, $21.84M total) across 2 trades on 2026-09-17. Filed jointly with RA Capital Healthcare Fund LP (Director), RA Capital Nexus Fund, L.P. (Director), RA Capital Nexus Fund III, L.P. (Director), Kolchinsky Peter (Director) and Shah Rajeev M. (Director).